Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Daniel Fankhauser

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
European Urology Focus|October 9, 2020
A Risk-benefit Analysis of Prophylactic Anticoagulation for Patients with Metastatic Germ Cell Tumours Undergoing First-line ChemotherapyChristian Daniel Fankhauser, Ben Tran, Manuel Pedregal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2023
Risk Factors for Relapse in Nonseminomatous Testicular Cancer After Postchemotherapy Retroperitoneal Lymph Node Dissection With Viable Residual CancerLuca Antonelli, Davide Ardizzone, Isamu Tachibana, et al.
World Journal of Urology|March 8, 2021
The prognostic significance of lactate dehydrogenase levels in seminoma patients with advanced disease: an analysis by the Global Germ Cell Tumor Collaborative Group (G3)Christoph Seidel, Gedske Daugaard, Tim Nestler, et al.
The Journal of Urology|September 22, 2021
An Algorithm to Personalize Nerve Sparing in Men with Unilateral High-Risk Prostate CancerAlberto Martini, Timo F W Soeterik, Hester Haverdings, et al.
European Urology Open Science|June 17, 2025
Prevalence and Prognostic Significance of Preoperative Anemia in Radical Cystectomy Patients: A Multicenter Retrospective Observational StudyErnest Kaufmann, Luca Antonelli, Luca Afferi, et al.
BJU International|July 4, 2024
Thromboprophylaxis during neoadjuvant chemotherapy for bladder cancer reduces thromboembolism and bleedingLuca Antonelli, Pedro David Wendel-Garcia, Manja Deforth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2019
Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric StudyKlaus-Peter Dieckmann, Arlo Radtke, Lajos Geczi, et al.
Clinical Genitourinary Cancer|December 28, 2023
The Prognostic Role of Preoperative PSMA PET/CT in cN0M0 pN+ Prostate Cancer: A Multicenter StudyGiancarlo Marra, Pawel Rajwa, Claudia Filippini, et al.
Prostate Cancer and Prostatic Diseases|January 5, 2024
An updated model for predicting side-specific extraprostatic extension in the era of MRI-targeted biopsyAlberto Martini, Lieke Wever, Timo F W Soeterik, et al.
Bladder Cancer (Amsterdam, Netherlands)|January 19, 2026
Interdisciplinary Swiss consensus recommendations for follow-up after radical cystectomy and trimodal treatment for muscle-invasive bladder cancerErnest Kaufmann, Stefanie Aeppli, Andres Affentranger, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
European Urology Focus|October 9, 2020
A Risk-benefit Analysis of Prophylactic Anticoagulation for Patients with Metastatic Germ Cell Tumours Undergoing First-line ChemotherapyChristian Daniel Fankhauser, Ben Tran, Manuel Pedregal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2023
Risk Factors for Relapse in Nonseminomatous Testicular Cancer After Postchemotherapy Retroperitoneal Lymph Node Dissection With Viable Residual CancerLuca Antonelli, Davide Ardizzone, Isamu Tachibana, et al.
World Journal of Urology|March 8, 2021
The prognostic significance of lactate dehydrogenase levels in seminoma patients with advanced disease: an analysis by the Global Germ Cell Tumor Collaborative Group (G3)Christoph Seidel, Gedske Daugaard, Tim Nestler, et al.
The Journal of Urology|September 22, 2021
An Algorithm to Personalize Nerve Sparing in Men with Unilateral High-Risk Prostate CancerAlberto Martini, Timo F W Soeterik, Hester Haverdings, et al.
European Urology Open Science|June 17, 2025
Prevalence and Prognostic Significance of Preoperative Anemia in Radical Cystectomy Patients: A Multicenter Retrospective Observational StudyErnest Kaufmann, Luca Antonelli, Luca Afferi, et al.
BJU International|July 4, 2024
Thromboprophylaxis during neoadjuvant chemotherapy for bladder cancer reduces thromboembolism and bleedingLuca Antonelli, Pedro David Wendel-Garcia, Manja Deforth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2019
Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric StudyKlaus-Peter Dieckmann, Arlo Radtke, Lajos Geczi, et al.
Clinical Genitourinary Cancer|December 28, 2023
The Prognostic Role of Preoperative PSMA PET/CT in cN0M0 pN+ Prostate Cancer: A Multicenter StudyGiancarlo Marra, Pawel Rajwa, Claudia Filippini, et al.
Prostate Cancer and Prostatic Diseases|January 5, 2024
An updated model for predicting side-specific extraprostatic extension in the era of MRI-targeted biopsyAlberto Martini, Lieke Wever, Timo F W Soeterik, et al.
Bladder Cancer (Amsterdam, Netherlands)|January 19, 2026
Interdisciplinary Swiss consensus recommendations for follow-up after radical cystectomy and trimodal treatment for muscle-invasive bladder cancerErnest Kaufmann, Stefanie Aeppli, Andres Affentranger, et al.
Pageof 7